Olivia Aranha

911 total citations
34 papers, 676 citations indexed

About

Olivia Aranha is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Olivia Aranha has authored 34 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Olivia Aranha's work include Colorectal and Anal Carcinomas (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Olivia Aranha is often cited by papers focused on Colorectal and Anal Carcinomas (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Olivia Aranha collaborates with scholars based in United States, France and Belgium. Olivia Aranha's co-authors include Fazlul H. Sarkar, David P. Wood, F. H. Sarkar, Samir Alhasan, KM Wahidur Rahman, Timothy McDonnell, Khalilur Rahman, David K. Wood, Sreenivasa R. Chinni and B. F. El-Rayes and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Olivia Aranha

28 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivia Aranha United States 13 398 213 129 91 83 34 676
Alex Philchenkov Ukraine 14 451 1.1× 123 0.6× 175 1.4× 47 0.5× 44 0.5× 39 812
Dawn R. Church United States 14 421 1.1× 128 0.6× 108 0.8× 138 1.5× 49 0.6× 23 675
Bulbul Pandit United States 18 594 1.5× 299 1.4× 276 2.1× 55 0.6× 116 1.4× 26 972
Hongfei Tong China 18 392 1.0× 133 0.6× 71 0.6× 82 0.9× 55 0.7× 36 867
Youqun Xiang China 17 347 0.9× 250 1.2× 51 0.4× 72 0.8× 84 1.0× 30 734
Yali Deng China 9 479 1.2× 240 1.1× 236 1.8× 43 0.5× 70 0.8× 13 802
Crescent R. Isham United States 10 354 0.9× 255 1.2× 93 0.7× 31 0.3× 70 0.8× 14 686
Qiangrong Pan China 13 689 1.7× 203 1.0× 119 0.9× 116 1.3× 45 0.5× 16 967
Liyan Chen China 18 581 1.5× 160 0.8× 55 0.4× 74 0.8× 66 0.8× 33 851
Ki Deok Shin South Korea 7 404 1.0× 186 0.9× 142 1.1× 48 0.5× 52 0.6× 7 711

Countries citing papers authored by Olivia Aranha

Since Specialization
Citations

This map shows the geographic impact of Olivia Aranha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Aranha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Aranha more than expected).

Fields of papers citing papers by Olivia Aranha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Aranha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Aranha. The network helps show where Olivia Aranha may publish in the future.

Co-authorship network of co-authors of Olivia Aranha

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Aranha. A scholar is included among the top collaborators of Olivia Aranha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Aranha. Olivia Aranha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ciombor, Kristen K., Lianchun Xiao, Enrica Marmonti, et al.. (2026). NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal. Journal of Clinical Oncology. 44(6). 497–507.
2.
Feng, Mary, Christopher L. Hallemeier, Olivia Aranha, et al.. (2025). Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline. Practical Radiation Oncology. 15(4). 367–386. 2 indexed citations
3.
Grierson, Patrick, Rama Suresh, Andrea Wang‐Gillam, et al.. (2025). Neoadjuvant BMS-813160, Nivolumab, Gemcitabine, and Nab-Paclitaxel for Patients with Pancreatic Cancer. Clinical Cancer Research. 31(17). 3644–3651.
4.
Morris, Van K., Erin B. Kennedy, Manik Amin, et al.. (2024). Systemic Therapy for Stage I-III Anal Squamous Cell Carcinoma: ASCO Guideline. Journal of Clinical Oncology. 43(5). 605–615. 3 indexed citations
5.
Morris, Van K., Joshua K. Ochieng, Kristen K. Ciombor, et al.. (2024). Changes in circulating immune biomarkers following nivolumab with or without ipilimumab for metastatic anal cancer (NCI9673).. Journal of Clinical Oncology. 42(3_suppl). 3–3. 1 indexed citations
6.
Morris, Van K., Kristen K. Ciombor, Blasé N. Polite, et al.. (2023). O-12 NCI9673 (Part B): A multi-institutional ETCTN randomized phase II study of nivolumab with or without ipilimumab in refractory, metastatic squamous cell carcinoma of the anal canal. Annals of Oncology. 34. S185–S186. 6 indexed citations
7.
Patel, Bindiya, et al.. (2023). Advances in systemic chemotherapy and immunotherapy for metastatic colorectal cancer. Seminars in Colon and Rectal Surgery. 34(3). 100972–100972.
8.
Wang‐Gillam, Andrea, Robert R. McWilliams, Rama Suresh, et al.. (2022). Phase I dose escalation and expansion study of defactinib, pembrolizumab, and gemcitabine in patients with advanced treatment-refractory pancreatic cancer.. Journal of Clinical Oncology. 40(16_suppl). 4146–4146. 1 indexed citations
9.
Sanjeevaiah, Aravind, Rama Suresh, Rutika Mehta, et al.. (2020). P-131 Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma: Interim analysis of a phase II trial. Annals of Oncology. 31. S132–S132. 1 indexed citations
10.
Kelemen, Katalin, LoAnn C. Peterson, Irene Helenowski, et al.. (2008). CD23+ Mantle Cell Lymphoma. American Journal of Clinical Pathology. 130(2). 166–177. 34 indexed citations
11.
Aranha, Olivia & Mark Agulnik. (2008). Molecularly targeted therapies in adult soft tissue sarcomas: present approach and future directions. Expert Opinion on Therapeutic Targets. 12(2). 197–207. 2 indexed citations
12.
Aranha, Olivia & Al B. Benson. (2007). Adjuvant therapy for Colon Cancer. Current Gastroenterology Reports. 9(5). 415–421. 13 indexed citations
13.
Ali, Shadan, B. F. El-Rayes, Olivia Aranha, Fazlul H. Sarkar, & Philip A. Philip. (2005). Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells. Breast Cancer Research and Treatment. 90(1). 25–31. 17 indexed citations
14.
Aranha, Olivia & Ulka N. Vaishampayan. (2004). PSA relapse prostate cancer: the importance of tailored therapy. Urologic Oncology Seminars and Original Investigations. 22(1). 62–69. 9 indexed citations
15.
Rahman, KM Wahidur, Olivia Aranha, & Fazlul H. Sarkar. (2003). Indole-3-Carbinol (I3C) Induces Apoptosis in Tumorigenic but Not in Nontumorigenic Breast Epithelial Cells. Nutrition and Cancer. 45(1). 101–112. 72 indexed citations
16.
Ali, Shadan, Olivia Aranha, Yiwei Li, et al.. (2003). Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1. Cancer Chemotherapy and Pharmacology. 52(3). 235–246. 19 indexed citations
17.
Aranha, Olivia, Li Zhu, Samir Alhasan, et al.. (2002). ROLE OF MITOCHONDRIA IN CIPROFLOXACIN INDUCED APOPTOSIS IN BLADDER CANCER CELLS. The Journal of Urology. 167(3). 1288–1294. 42 indexed citations
18.
El-Rayes, B. F., et al.. (2002). Ciprofloxacin inhibits cell growth and synergises the effect of etoposide in hormone resistant prostate cancer cells. International Journal of Oncology. 21(1). 207–11. 52 indexed citations
19.
Rahman, Khalilur, et al.. (2000). Translocation of Bax to mitochondria induces apoptotic cell death in Indole-3-carbinol (I3C) treated breast cancer cells. Oncogene. 19(50). 5764–5771. 76 indexed citations
20.
Alkatib, Aziz A., et al.. (1999). Molecular effects of taxol and caffeine on pancreatic cancer cells.. International Journal of Molecular Medicine. 4(5). 501–7. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alex Philchenkov Breakdown of academic impact, for papers by Dawn R. Church Breakdown of academic impact, for papers by Bulbul Pandit Breakdown of academic impact, for papers by Hongfei Tong Breakdown of academic impact, for papers by Youqun Xiang Breakdown of academic impact, for papers by Yali Deng Breakdown of academic impact, for papers by Crescent R. Isham Breakdown of academic impact, for papers by Qiangrong Pan Breakdown of academic impact, for papers by Liyan Chen Breakdown of academic impact, for papers by Ki Deok Shin
Rankless by CCL
2026